Evidence map›Paper›PMID 30279342›Full record

ArticleInternational journal of molecular sciences2018

Inhibition of Tetraspanin Functions Impairs Human Papillomavirus and Cytomegalovirus Infections.

Laura A Fast, Snježana Mikuličić, Anna Fritzen, Jonas Schwickert, Fatima Boukhallouk, Daniel Hochdorfer, Christian Sinzger, Henar Suarez, Peter N Monk, María Yáñez-Mó and 2 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Assessment of TSPAN Expression Profile and Their Role in the VSCC Prognosis.International journal of molecular sciences · 2021
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Tetraspanin CD81 regulates HSV-1 infection.Medical microbiology and immunology · 2020
    Article
  18. Article
  19. HPV caught in the tetraspanin web?Medical microbiology and immunology · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Laura A FastInstitute for Virology and Research Center for Immunotherapy (FZI), University Medical Center of the Johannes Gutenberg University, 55122 Mainz, Germany. laura.fast@uni-mainz.de.ORCID 0000-0002-4041-8917
Snježana MikuličićInstitute for Virology and Research Center for Immunotherapy (FZI), University Medical Center of the Johannes Gutenberg University, 55122 Mainz, Germany. snjezana.mikulicic@gmail.com.
Anna FritzenInstitute for Virology and Research Center for Immunotherapy (FZI), University Medical Center of the Johannes Gutenberg University, 55122 Mainz, Germany. fritzenaen@t-online.de.
Jonas SchwickertInstitute for Virology and Research Center for Immunotherapy (FZI), University Medical Center of the Johannes Gutenberg University, 55122 Mainz, Germany. jonas.schwickert@web.de.
Fatima BoukhalloukInstitute for Medical Microbiology and Hygiene, University Medical Center of the Johannes Gutenberg University, 55122 Mainz, Germany. bouk@uni-mainz.de.
Daniel HochdorferInstitute of Virology, Ulm University Medical Center, 89081 Ulm, Germany. danielhochdorfer@gmail.com.
Christian SinzgerInstitute of Virology, Ulm University Medical Center, 89081 Ulm, Germany. Christian.Sinzger@uniklinik-ulm.de.
Henar SuarezDepartamento de Biología Molecular, UAM, 28049 Madrid, Spain. henar.suarez.montero@gmail.com.
Peter N MonkDepartment of Infection, Immunity and Cardiovascular Disease, School of Medicine and Biomedical Science, University of Sheffield, Sheffield S10 2RX, England, UK. p.monk@sheffield.ac.uk.ORCID 0000-0003-4637-3059
María Yáñez-MóDepartamento de Biología Molecular, UAM, 28049 Madrid, Spain. maria.yannez@uam.es.ORCID 0000-0001-7484-2866
Diana LieberInstitute of Virology, Ulm University Medical Center, 89081 Ulm, Germany. diana_lieber@gmx.de.
Luise FlorinInstitute for Virology and Research Center for Immunotherapy (FZI), University Medical Center of the Johannes Gutenberg University, 55122 Mainz, Germany. lflorin@uni-mainz.de.ORCID 0000-0003-4310-7329

Funding

Deutsche Forschungsgemeinschaft DFG; FL 696/2-1, FL 696/3-1Deutscher Akademischer Austauschdienst DAADMinisterio de Economía y Competitividad BFU2014-55478-R, BIO2017-86500-R
6 · The paper itself

Abstract

Tetraspanins are suggested to regulate the composition of cell membrane components and control intracellular transport, which leaves them vulnerable to utilization by pathogens such as human papillomaviruses (HPV) and cytomegaloviruses (HCMV) to facilitate host cell entry and subsequent infection. In this study, by means of cellular depletion, the cluster of differentiation (CD) tetraspanins CD9, CD63, and CD151 were found to reduce HPV16 infection in HeLa cells by 50 to 80%. Moreover, we tested recombinant proteins or peptides of specific tetraspanin domains on their effect on the most oncogenic HPV type, HPV16, and HCMV. We found that the C-terminal tails of CD63 and CD151 significantly inhibited infections of both HPV16 and HCMV. Although CD9 was newly identified as a key cellular factor for HPV16 infection, the recombinant CD9 C-terminal peptide had no effect on infection. Based on the determined half-maximal inhibitory concentration (IC

Indexed as

CytomegalovirusCytomegalovirus InfectionsHeLa CellsHuman papillomavirus 16HumansInhibitory Concentration 50MalePeptidesTetraspaninsVirus InternalizationPeptidesTetraspaninsblocking peptideHPV16human cytomegalovirushuman papillomavirusIC50tetraspaninvirus entry

Identifiers

PMID30279342
PMCPMC6212908

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.